
|Articles|December 9, 2014
When to Consider a Clinical Trial?
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease.
Advertisement
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease. In this
The video features expert insights from:
- Larisa Geskin, MD, Associate Professor of Dermatology, University of Pittsburgh
- Stuart Lessin, MD, Medical Director, KGL Skin Study Center, Broomall, PA
- Pierluigi Porcu, MD, Associate Professor of Internal Medicine, Division of Hematology-Oncology, Ohio State University Comprehensive Cancer Center
- Marianne Tawa, RN, MSN, ANP, Nurse Practitioner, Dermatology and Cutaneous Oncology, Dana Farber Cancer Institute
This video is one of several featured in the CLF’s Online Learning Center. Other topics include recommendations for managing itch and a three-part overview of treatments for cutaneous lymphoma.
For more information, visit
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
3
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
4
FDA Approves Oral Nilotinib Tablets for Ph+ CML
5






























































